메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Lee Jaemin (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University) 송찬우 (경상국립대학교) 노인환 (경상국립대학교) 이윤석 (경상국립대학교)
저널정보
한국약제학회 Journal of Pharmaceutical Investigation Journal of Pharmaceutical Investigation Vol.54 No.2
발행연도
2024.3
수록면
175 - 193 (19page)
DOI
10.1007/s40005-024-00675-w

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background An increasing number of pharmaceutical formulations are currently being developed via 3D printing, which has placed growing importance on design for 3D printing. 3D printing technology enables the creation of custom parts and devices in geometrically complex and composite materials that cannot be produced using traditional manufacturing methods. To fully take advantage of these capabilities, design for 3D printing, also known as design for additive manufacturing (DfAM), is required. Area covered This paper provides a variety of examples of how DfAM is being applied and utilized in the pharmaceutical field to produce pharmaceuticals using 3D printing, including oral solid dosage forms, microneedles, implants, and more. Expert opinion The integration of DfAM factors into the formulation of 3D printed pharmaceuticals enables the production of complex structures, the incorporation of multiple APIs for controlled drug release, and the integration of multiple functionalities into a single dosage form, none of which can be attained through traditional pharmaceutical manufacturing. 3D printing could be a complementary tool for producing different drug dosage forms or patient-tailored formulations that are difficult to produce using traditional pharmaceutical production systems.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0